FDA approves first new type of pain medication in 25 years
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
Hosted on MSN2mon
Nerve damage reduced in prediabetic mice with diet, exercise
When someone has neuropathy, AMPK activity is reduced, which is associated with lower energy levels and nerve injury. Dietary intervention, alone or coupled with HIIT, boosted AMPK activation in ...
BioSpace2d
Algiax’s Non-Opioid Drug Reduces Neuropathic Pain in Mid-Stage Trial
The Phase IIa results continue a surge of momentum in a treatment space that last week saw the approval of Vertex’s Journavx ...
Many cancer patients experience nerve pain from chemo
Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new review suggests.
Hosted on MSN9h
USPTO grants patent to Vistagen’s neuropathic pain treatment
The US Patent and Trademark Office (USPTO) has granted a patent to Vistagen’s non-opioid oral product candidate, AV-101 for neuropathic pain treatment. This patent is set to remain in effect until at ...
News Medical on MSN8d
Cancer drugs cause chronic peripheral nerve pain in 40% of patients
Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around four in every 10 patients treated with these drugs, suggests a pooled data analysis of the ...